Cetirizine Safety in First Trimester of Pregnancy
Cetirizine is safe to use during the first trimester of pregnancy, with extensive human data showing no significant increase in congenital malformations.
Evidence Supporting Safety
The safety of cetirizine during early pregnancy is well-established through multiple lines of evidence:
Guideline Recommendations
Second-generation antihistamines, including cetirizine, have confirmed safety for first trimester use through large birth registries, case-control studies, and cohort studies 1.
Both first-generation and second-generation antihistamines demonstrate excellent safety records with no significant increase in congenital malformations when used during the first trimester 1.
Loratadine and cetirizine are specifically recommended as preferred antihistamines in pregnancy because they have been the most extensively studied second-generation agents 2, 3.
Clinical Study Data
A prospective observational cohort study of 196 pregnancies exposed to cetirizine during the first trimester found no increased risk of major birth defects (OR 1.07; CI 0.21-3.59), spontaneous abortions, preterm deliveries, or differences in birth weight 4.
Analysis of 228 pregnancies with maternal cetirizine exposure (mostly first trimester) showed 83.7% resulted in live births, with only 2 congenital malformations reported—rates consistent with background population rates 5.
A meta-analysis confirmed cetirizine is not associated with clinically important increases in adverse fetal outcomes 6.
A prospective controlled study of 39 cetirizine-exposed pregnancies found no significant differences in rates of live births, spontaneous/therapeutic abortions, stillbirths, or major/minor anomalies compared to controls 7.
Important Caveats
Antihistamines to Avoid
While cetirizine is safe, certain other antihistamines require caution:
Hydroxyzine should be used cautiously during the first trimester based on animal data 1.
Diphenhydramine has some concern regarding association with cleft palate, though recent studies have not confirmed increased risk 1.
Limited Data Agents
- Desloratadine, azelastine, and levocetirizine have limited data available, making cetirizine a more evidence-based choice 1.
FDA Labeling Guidance
The FDA drug label for cetirizine states: "if pregnant: ask a health professional before use" 8. However, this conservative labeling does not reflect the substantial reassuring human data that has accumulated.
Clinical Application
When treating allergic rhinitis or urticaria in the first trimester:
Cetirizine or loratadine should be first-line antihistamine choices given their extensive safety data 2, 3.
The critical period for organogenesis is the first trimester, making medication selection during this time particularly important 1.
Managing allergy symptoms adequately during pregnancy is important to reduce maternal and fetal complications 3, 5.
If antihistamines are used during the last 2 weeks of pregnancy, one study reported association with retrolental fibroplasia in premature infants, though this has not been corroborated 2.